Cargando…
Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study
BACKGROUND: Self-administered subcutaneous immunoglobulin G (SCIg) reduces nursing time and eliminates the need for treatment at ambulatory care clinics, as compared with clinic-based intravenously administered IgG (IVIg), and are therapeutically equivalent. Estimating the economic impact of self-ad...
Autores principales: | Ritchie, Bruce, Martins, Karen J. B., Tran, Dat T., Blain, Heather, Richer, Lawrence, Klarenbach, Scott W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700869/ https://www.ncbi.nlm.nih.gov/pubmed/36434668 http://dx.doi.org/10.1186/s13223-022-00735-6 |
Ejemplares similares
-
Bioavailability of IgG Administered by the Subcutaneous Route
por: Berger, Melvin, et al.
Publicado: (2013) -
Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada
por: Lee, Cerina, et al.
Publicado: (2021) -
Economic analysis of pharmacist-administered influenza vaccines in Ontario, Canada
por: O’Reilly, Daria J, et al.
Publicado: (2018) -
Health resource utilization, costs, and community treatment order status before and after the initiation of second-generation long acting-injectable antipsychotics in patients with schizophrenia in Alberta, Canada
por: Chue, P., et al.
Publicado: (2022) -
The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta
por: Akpinar, Ilke, et al.
Publicado: (2019)